DALLAS, TX--(Marketwire - January 28, 2010) -
Highlighted Links |
http://www.projectprotectthekids.com |
http://www.biotechmedics.com |
"This event is unique in that it consists of one-on-one meeting sessions scheduled with over 50 major European Suppliers and Buyers, their top executives and CEOs to review personally our new SHBAN Alcohol Free Hand Sanitizer to consider promoting, marketing and/or distributing SHBAN throughout Europe," said Keith Houser, BioTech's CEO.
"These 20 minute or longer meetings take place in SHBAN's private suite. These meetings replace 'cold call' sales presentations in the buyer's office saving time and money," said Mr. Houser. "During each session, both parties indicate their level of interest and follow up with scheduled private evening negotiation sessions. We are excited about this event and anticipate that BioTech will receive several offers from major distributors in Europe to represent and carry SHBAN."
SHBAN has been tested extensively for over 12 years. SHBAN was invented by Edward J. Cragoe, Jr. PhD. who has invented over 19 drugs in his career. SHBAN has been independently clinically proven to kill the H1N1 (Swine) Influenza A virus. SHBAN has been evaluated for its antimicrobial properties against MRSA, Staph. Aureus, Staph. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa.
SHBAN is a bio-degradable product superior to most anti-bacterial antiseptics because 1) SHBAN is longer lasting, SHBAN does not evaporate within 15 seconds after application and cease working (like alcohol gels); 2) SHBAN is non-toxic when used as directed on humans (over 22,000 alcohol poisoning calls have been placed to the Poison Control Center within the past 3 years); 3) SHBAN is non-staining; 4) SHBAN is non-flammable and 5) SHBAN has no toxic odors. Most hand sanitizer products cannot make all of these claims.
Safe Harbor: Forward-Looking Statements
This release contains forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995 (the "Act"). SHBAN has not
been evaluated by the FDA. SHBAN is not intended to diagnose, treat or cure
any disease.
Contact:
Keith Houser
CEO
Phone: 972-274-5533